Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment

NCT07069842 is registered in ClinicalTrials.gov with Changzhi People's Hospital Affiliated to Changzhi Medical College as lead sponsor.

NCT NCT07069842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07069842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment
Lead sponsor
Changzhi People's Hospital Affiliated to Changzhi Medical College
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2026
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer, immunotherapy